Johnson & Johnson ordered to pay $417 million to woman in talcum lawsuit


A 63-year-old woman with terminal ovarian cancer was awarded $417 million on Monday after a jury in Los Angeles found Johnson & Johnson liable for not warning her about the risks of using the company's talcum products.
Eva Echeverria's lawsuit is one of 4,500 in the United States that allege Johnson & Johnson disregarded studies that link its baby powder and Shower to Shower products with ovarian cancer. The jury awarded her $347 million in punitive damages and $70 million in compensatory damages, and found there was a connection between her cancer and the powder. Echeverria, who was diagnosed with cancer in 2007, said she started using Johnson & Johnson's baby powder at age 11 and didn't stop until 2016; Echeverria testified she would have quit much sooner had she known about the link.
Her lawsuit cited a 1982 study that showed women who put talc on their genitals had a 92 percent increased risk for ovarian cancer, with the head researcher telling Johnson & Johnson it should put warning labels on its products, the Los Angeles Times reports. Johnson & Johnson, which said it plans on appealing the verdict, cited a different study from 2000, where researchers stated there was "no overall association" between talc use and epithelial ovarian cancer, but there was a "modest elevation in risk" for the type of cancer Echeverria has — serious ovarian cancer. She was not in the courthouse when the jury made its ruling, her attorney said, because she was too ill to attend.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Does depopulation threaten humanity?
Talking Points Falling birth rates could create a 'smaller, sadder, poorer future'
-
New White House guidance means federal employees could be hearing more religious talk at work
The Explainer Employees can now try to persuade co-workers of why their religion is 'correct'
-
Real-life couples creating real-deal sparks in the best movies to star IRL partners
The Week Recommends The chemistry between off-screen items can work wonders
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year
-
Economists fear US inflation data less reliable
speed read The Labor Department is collecting less data for its consumer price index due to staffing shortages
-
Crypto firm Coinbase hacked, faces SEC scrutiny
Speed Read The Securities and Exchange Commission has also been investigating whether Coinbase misstated its user numbers in past disclosures
-
Starbucks baristas strike over dress code
speed read The new uniform 'puts the burden on baristas' to buy new clothes, said a Starbucks Workers United union delegate
-
Warren Buffet announces surprise retirement
speed read At the annual meeting of Berkshire Hathaway, the billionaire investor named Vice Chairman Greg Abel his replacement